Search research articles
Contact Us
Filters
Showing results (1-10 of 92) with videos related to
Page
of 10
Sort By:
Expert Opinion on Drug Safety
|
September 24, 2015
Risk-adapted strategies for the treatment of Hodgkin lymphoma
Jesse Keller, Kenneth R Carson
Expert Opinion on Drug Safety
|
May 14, 2014
A drug safety evaluation of rituximab and risk of hepatitis B
Peter Riedell, Kenneth R Carson
Fertility and Sterility
|
April 15, 2018
Leveraging real-world data to move toward more personalized fertility treatment
Emily S Jungheim, Kenneth R Carson
Leukemia & Lymphoma
|
April 7, 2009
Rituximab and progressive multi-focal leukoencephalopathy: the jury is deliberating
Kenneth R Carson, Charles L Bennett
JCO Oncology Practice
|
December 18, 2020
Contemporary Clinical Trials Office: Doing More With Less
Kenneth R Carson, Charles L Bennett
Blood
|
January 30, 2010
Successful treatment of IgM-mediated autoimmune hemolytic anemia with bortezomib
Kenneth R Carson, Lee G Beckwith, Jayesh Mehta
Cancer Treatment and Research
|
November 30, 2022
Rituximab-Associated Progressive Multifocal Leukoencephalopathy: A Twenty-Year Update
Charles L Bennett, Bartlett Witherspoon, Kenneth R Carson
Cancer Treatment and Research
|
September 3, 2010
Counseling and consenting women with cancer on their oncofertility options: a clinical perspective
Emily S Jungheim, Kenneth R Carson, Douglas Brown
Seminars in Oncology
|
November 9, 2019
Reflections on and future of hematologic malignancies research in the Veterans Health Administration
Daphne R Friedman, Kenneth R Carson, J Brice Weinberg
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 7, 2017
Reply to S. Suissa et al
Kristen M Sanfilippo, Suhong Luo, Brian F Gage, et al.
Page
of 10
Search research articles
Search
Showing results (1-10 of 92) with videos related to
Sort By:
Page
of 10
Expert Opinion on Drug Safety
|
September 24, 2015
Risk-adapted strategies for the treatment of Hodgkin lymphoma
Jesse Keller, Kenneth R Carson
Expert Opinion on Drug Safety
|
May 14, 2014
A drug safety evaluation of rituximab and risk of hepatitis B
Peter Riedell, Kenneth R Carson
Fertility and Sterility
|
April 15, 2018
Leveraging real-world data to move toward more personalized fertility treatment
Emily S Jungheim, Kenneth R Carson
Leukemia & Lymphoma
|
April 7, 2009
Rituximab and progressive multi-focal leukoencephalopathy: the jury is deliberating
Kenneth R Carson, Charles L Bennett
JCO Oncology Practice
|
December 18, 2020
Contemporary Clinical Trials Office: Doing More With Less
Kenneth R Carson, Charles L Bennett
Blood
|
January 30, 2010
Successful treatment of IgM-mediated autoimmune hemolytic anemia with bortezomib
Kenneth R Carson, Lee G Beckwith, Jayesh Mehta
Cancer Treatment and Research
|
November 30, 2022
Rituximab-Associated Progressive Multifocal Leukoencephalopathy: A Twenty-Year Update
Charles L Bennett, Bartlett Witherspoon, Kenneth R Carson
Cancer Treatment and Research
|
September 3, 2010
Counseling and consenting women with cancer on their oncofertility options: a clinical perspective
Emily S Jungheim, Kenneth R Carson, Douglas Brown
Seminars in Oncology
|
November 9, 2019
Reflections on and future of hematologic malignancies research in the Veterans Health Administration
Daphne R Friedman, Kenneth R Carson, J Brice Weinberg
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 7, 2017
Reply to S. Suissa et al
Kristen M Sanfilippo, Suhong Luo, Brian F Gage, et al.
Page
of 10